Molnupiravir (or MONEYpiravir): Merck pill used to combat Covid-19 failed to demonstrate it can lower the risk of hospitalization compared with a placebo among adults at a higher risk from the disease
palexander.substack.com
Molnupiravir (or MONEYpiravir): Merck pill used to combat Covid-19 failed to demonstrate it can lower the risk of hospitalization compared with a placebo among adults at a higher risk from the disease
Merck’s Covid-19 pill was no better than placebo in lowering the risk of hospitalization; Molnupiravir can mutate DNA that can cause Cancer, Infertility, Birth Defects
Molnupiravir (or MONEYpiravir): Merck pill used to combat Covid-19 failed to demonstrate it can lower the risk of hospitalization compared with a placebo among adults at a higher risk from the disease
Substack Alexander COVID News evidence-based medicine is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.
Propaganda works. So many people will still take this instead of vitamin D this Winter.
Too bad they didn't compare it to Ivermectin or HCQ or another half does drugs that work.